However, we also disagree with Henderson and Andrews on several points.

The first paragraph of their article raises a concern that the resources used to carry out psychiatric epidemiological surveys might be better used to address the problem of unmet need for treatment. This criticism is ill-conceived. These surveys make it clear that an increase in healthcare resources is required to address the enormous problem of unmet need for treatment of mental disorders. Needs assessment surveys must be carried out to document this unmet need, as well as to track changes in unmet need as mental healthcare policies change. It is a mistake to set the cost of carrying out these surveys in opposition to the need for increased treatment resources. This is especially so in light of the fact that the resources needed to carry out a typical large-scale psychiatric epidemiological survey (e.g. face-to-face interviews with a representative sample of 5000 respondents) are trivial in relation the resources needed to provide treatment. The former resources amount to about 25 person-years. In a country of 40 million people with a 15% prevalence of mental illness, this comes to roughly 1 minute per person with a mental illness. Not much good can be done in 1 minute of treatment. Much more good could be done by investing that minute in a needs assessment survey that documents the magnitude of unmet need for treatment, obtains information about misallocation of treatment resources, and provides a firm foundation for seeking expanded treatment resources and implementing more efficient outreach and treatment initiatives.

We also take issue with the characterisation by Henderson and Andrews of recent psychiatric epidemiological surveys being based exclusively on categorical diagnostic assessments and excluding environmental risk factors. The World Mental Health Surveys include structured versions of disorder-specific symptom severity scales, such as the Quick Inventory of Depressive Symptomatology (Rush *et al*, [@r7]) for major depression and the Panic Disorder Severity Scale (Houck *et al*, [@r1]) for panic disorder. In addition, all respondents are administered the dimensional Kessler Psychological Distress Scale (K--10) (Kessler *et al*, [@r3]), as well as separate dimensional assessments of disability. With regard to environmental risk factors, the surveys include a detailed assessment of childhood adversity, which is a focus of ongoing causal analysis.

We agree with Henderson and Andrews that differences in fundamental survey conditions make it most useful to study comparative, within-country correlates. We also agree that socio-demographic correlates, such as the higher prevalence of depression among women than men, are by now so well known that we need to investigate causes rather than merely replicate these associations in new surveys. The survey analyses are doing just that. For example, we are examining the role of cross-national differences in age at menarche and in gender roles in accounting for time--space variation in the association between gender and depression. Preliminary results suggest that the gender gap in depression is becoming significantly smaller in numerous countries because of changes in the social roles of women (as indicated by trends in such things as rates of female labour force participation, access to birth control and delays in age at first child-bearing).

We agree with the spirit of Henderson and Andrews' conclusion that future surveys might profitably use brief screening scales rather than diagnostic interviews. However, the use of screening scales needs to be coupled with diagnostic interviews in targeted sub-samples to realise their full potential. At least three different types of integration are important in this way. We briefly discuss each of these three below.

There is a key question in this regard. What do we gain and what do we lose by using short screening scales rather than long diagnostic interviews to assess mental illness in community epidemiological surveys? The first part of the answer is very simple: the brevity of screening scales allows them to be included in ongoing omnibus government health-tracking surveys, whereas diagnostic interviews are too lengthy to be included in omnibus surveys. By the term 'omnibus survey' we mean multi-purpose surveys that ask respondents about the presence, severity and course of physical and mental disorders, often along with questions about health service utilisation, health protective behaviours and health risks.

Screening scales are commonly included in omnibus health surveys, making it possible to assess many more people than in psychiatric epidemiological surveys. For example, the K--6 screening scale of non-specific psychological distress (Kessler *et al*, [@r3]) is included in all three major omnibus government health-tracking surveys in the USA:

-   the Behavioral Risk Factor Surveillance Survey (BRFSS; <http://www.cdc.gov/brfss>; 350 000 respondents per year interviewed by telephone in monthly replicates representative of each city, county and state in the USA)

-   the National Household Survey of Drug Use and Health (NHSDUH; <http://www.oas.samhsa.gov/nhsda.htm>; 70 000 respondents per year interviewed face-to-face in quarterly replicates representative of the largest states as well as of each census division in the USA)

-   the National Health Interview Survey (NHIS; <http://www.cdc.gov/nchs/nhis.htm>; 50 000 respondents per year interviewed face-to-face in monthly replicates representative of each census division in the USA).

Clinical calibration studies show that the K--6 is an excellent screening scale for the global assessment of broadly defined DSM--IV anxiety and mood disorders (Kessler *et al*, [@r4]). Simple transformation rules consequently can be applied to K--6 scores to estimate the prevalence and correlates of recently occurring anxiety and mood disorders. To do this, though, we need to have faith in the calibration rules that link K--6 scores with DSM--IV diagnoses. This requires *ongoing* calibration in the omnibus surveys in which the K--6 is administered, because we need to know if any significant time trends in estimated prevalence are due to changes in true prevalence or to changes in the concordance of the K--6 with true prevalence. Recognising the importance of ongoing calibration, an initiative is currently under way in the USA to administer follow-up diagnostic interviews to a representative sub-sample of respondents in government omnibus health surveys, to refine K--6 calibration rules over time. This is the first of the three important ways in which clinical interviews can be integrated with screening scales.

Screening scales are limited because they include only broad-gauged information. When we discovered, for example, that the K--6 scores in the NHIS increased dramatically after the terrorist attacks of 11 September 2001, we had no way to know the extent to which this was owing to rises in adjustment disorder, post-traumatic stress disorder, major depression, other disorders, or various combinations of disorders. Nor could we tell the extent to which the K--6 increases were owing to first onsets versus recurrences of mental disorders. It would have been fairly simple to obtain this information with in-depth follow-up interviews. We might even have followed such cases over time to study the persistence and severity of post-disaster mental illness, patterns of help-seeking and modifiable barriers to treatment. Such information could have been of great value to the authorities. This is the second important way in which clinical interviews could be integrated with screening scales. An initiative of this sort is currently under way in the USA to embed follow-up psychiatric diagnostic risk factor interviews into the BRFSS in the wake of future large-scale natural and human-made disasters (Kessler *et al*, [@r6]).

The same limitations of screening scales also exist in interpreting cross-sectional associations. Furthermore, typical omnibus surveys include only superficial questions about treatment of emotional problems, and no questions about barriers to such treatment or about disablements caused by emotional problems. More in-depth assessments are needed to collect such data. An argument consequently could be made that a probability sub-sample of respondents in omnibus health surveys should be administered in-depth follow-up psychiatric interviews to collect this additional information. The second-stage sub-samples would over-sample respondents with high K--6 scores so as to enrich the sample for cases, making this the third important way in which clinical interviews could be integrated with screening scales.

We are currently investigating the possibility of using this design in the USA. Rather than continue to replicate the National Comorbidity Survey (NCS) in point-in-time surveys each decade (Kessler *et al*, [@r2], [@r5]), we would administer an NCS interview to a probability sample of omnibus survey respondents every month of every year, accumulating a sample of 12 000 cases over each decade. This approach has several advantages over the stand-alone survey method:

-   increased statistical power to study respondents with mental illness by over-sampling those who are 'positive' according to the screening scales

-   expansion of information on respondents from the omnibus survey

-   fine-grained time trend information

-   the ability to modify assessments quickly, rather than once a decade, when modifications would be useful.

Finally, as omnibus surveys are typically very large, we could target selection of follow-up sub-samples in ever-changing ways over time for purposes of refining causal analyses in a case--control framework. Respondent burden would increase and further elaboration would be needed to launch longitudinal studies, but this general approach holds much promise to realise the greater potential of general-purpose psychiatric epidemiological surveys along the lines so rightly urged by Henderson and Andrews.
